Skip to main content
CDXS
NASDAQ Industrial Applications And Services

Codexis wraps up $23.1M public offering at $1.50/share, issuing 16.7M shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.55
Mkt Cap
$140.89M
52W Low
$0.958
52W High
$3.87
52W Position info
62% above low
Off High info
60% below high
Rel. Volume info
3.5× avg
Market data snapshot near publication time

CDXS sits 62% above its 52-week low of $0.958 on elevated volume (3.5× avg).

Summary

Codexis closed its public offering of 16.7 million shares at $1.50 per share, raising $23.1 million in net proceeds. The offering was priced at a 5% discount to the prior close and adds to the company's cash reserves, but dilutes existing shareholders.


Key Events · Financing and Capital Events · CDXS

  • Offering Closed

    With the issuance of 16,666,667 shares at $1.50 apiece, the company raised approximately $23.1 million in net proceeds after underwriting discounts and expenses.

  • Dilution Impact

    The addition of 16.7 million shares represents significant dilution for existing holders. Underwriters also hold a 30-day option to purchase up to 2.5 million additional shares.

  • Use of Proceeds

    Net proceeds of $23.1 million are earmarked for general corporate purposes, extending the cash runway from the pre-offering balance of $54.9 million.

  • Insider Lock-Up

    All directors and executive officers have agreed to a 90-day lock-up, barring share sales until October 21, 2026.


Analysis · CDXS · Industrial Applications And Services

The previously announced public offering has now closed, with 16.7 million shares issued at $1.50 each, yielding net proceeds of $23.1 million. Priced at a 5% discount to the pre-announcement close, the stock has since settled at $1.55, suggesting the market is absorbing the dilution. The capital infusion extends the company's cash runway from the pre-offering level of $54.9 million, and a 90-day lock-up on insider sales signals alignment. Still, the issuance represents significant dilution for existing shareholders.

At the time of this filing, CDXS was trading at $1.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $140.9M. The 52-week trading range was $0.96 to $3.87. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDXS - Latest Insights

CDXS
Jul 24, 2026, 6:24 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $1.52 info
Change: +$0.0306 (+2%) info
Market Cap: $140.89M info
CDXS
Jul 23, 2026, 11:48 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.52 info
Change: -$0.0597 (-4%) info
Market Cap: $140.89M info
CDXS
Jul 23, 2026, 4:13 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $1.52 info
Change: -$0.0897 (-6%) info
Market Cap: $140.89M info
CDXS
May 07, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $1.52 info
Change: -$1.18 (-44%) info
Market Cap: $140.89M info
CDXS
Mar 11, 2026, 4:39 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.52 info
Change: -$0.1297 (-8%) info
Market Cap: $140.89M info